Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 8,269 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Risk Clear all

Conditions: Breast Cancer, Lobular Carcinoma, Invasive Breast Cancer
Interventions: Tissue specimen; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Female only
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Risk Factor
Interventions: Moderate Potassium/Low Sodium Diet, Moderate Potassium/High Sodium Diet, High Potassium/High Sodium Diet; Other
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 45 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Prostate Cancer
Interventions: sargramostim, thalidomide, conventional surgery, neoadjuvant therapy; Biological · Drug · Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Up to 120 Years · Male only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Myelodysplastic Syndrome
Interventions: pracinostat, Placebo, Azacitidine; Drug
Lead sponsor: Helsinn Healthcare SA; Industry
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 24
States / cities: Mobile, Alabama • La Jolla, California • Denver, Colorado + 21 more

Conditions: Physical Inactivity
Interventions: Cognitive training, Exercise; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 40 Years to 65 Years
Enrollment: 264 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Iowa City, Iowa • Boston, Massachusetts

Conditions: Health Behavior
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 7 Years to 16 Years
Enrollment: 14,350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit, Risk Reduction
Interventions: Semi Quantitative Food Frequency Questionnaire (SQFFQ); Behavioral
Lead sponsor: San Raffaele University; Other
Eligibility: 18 Years to 49 Years
Enrollment: 2,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2035
U.S. locations: 2
States / cities: Denver, Colorado • Chicago, Illinois

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Astute Medical, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 23
States / cities: Loma Linda, California • Los Angels, California • Washington D.C., District of Columbia + 18 more

Conditions: Anemia
Interventions: Lenalidomide, Placebo; Drug · Other
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 7
States / cities: Los Angeles, California • Centralia, Illinois • Lebanon, New Hampshire + 4 more

Conditions: Atrial Fibrillation, Atrial Flutter, Stroke, Embolism, Systemic Arterial, Major Bleeding
Interventions: Home Monitoring Guided OAC, Physician-Directed OAC; Drug
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,718 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 73
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 70 more

Conditions: Healthy Participants
Interventions: Metaxalone m640 mg oral tablet, Metaxalone 800 mg oral tablet; Drug
Lead sponsor: Primus Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Human Immunodeficiency Virus
Interventions: Antiretrovirals; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 24 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 3
States / cities: Los Angeles, California • New Orleans, Louisiana

Conditions: Externalizing Behavior
Interventions: Summer Academy; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 4 Years to 6 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Sexual Assault, Substance Use, Risky Health Behavior, Ema
Interventions: Ecological Momentary Intervention; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Treponema Pallidum, Treponema Pallidum Infection, Syphilis Infection, Serum, Plasma, Blooddraw, Sexually Transmitted Infection (STI)
Interventions: ALPCO Syphilis-T, ALPCO Syphilis-NT CLIA Kits; Device
Lead sponsor: American Laboratory Products Company; Industry
Eligibility: 13 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Lancaster, California • Los Angeles, California • North Miami, Florida + 3 more

Conditions: High Risk Pregnancy, Cesarean Wound Disruption With Postnatal Complication
Interventions: PICO Single Use Negative Pressure Wound Therapy; Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older · Female only
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Neutropenia, Sickle Cell Disease
Interventions: Decitabine; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Substance Use
Interventions: neurocognitive tasks; Other
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2029
U.S. locations: 2
States / cities: Blacksburg, Virginia • Roanoke, Virginia

Conditions: Neoplasms, Prostate
Interventions: Dutasteride, Matching placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years to 80 Years · Male only
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 58
States / cities: Little Rock, Arkansas • Beverly Hills, California • Laguna Hills, California + 54 more

Conditions: Smoking, Tobacco Use
Interventions: Laboratory task modeling smoking lapse behavior; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Stimulant Abuse, Criminal Behavior
Interventions: Decision task; Other
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 334 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Atrial Fibrillation
Interventions: Standard Care; Other
Lead sponsor: Danbury Hospital; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Danbury, Connecticut

Conditions: Breast Cancer
Interventions: Elacestrant, Anastrozole, Letrozole, Exemestane, Tamoxifen; Drug
Lead sponsor: Stemline Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 4,556 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 170
States / cities: Daphne, Alabama • Chandler, Arizona • Gilbert, Arizona + 134 more

Conditions: Appendicitis
Interventions: antibiotic duration; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Louisville, Kentucky

Search by objective public record fields.

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans

GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer

Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome

Cognitive Control to Boost Physical Activity Adherence

Health Behaviors in School-age Children: A World Health Organization Cross-National Study

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury

A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

Effectiveness Evaluation of a Comprehensive School Readiness Summer Program for Young Children At-Risk

Nexus of Risk: Sexual Assault, Alcohol Use, and Risky Sex Among College Women

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients

Decitabine for High-Risk Sickle Cell Disease

Neurocognitive Predictors of Health Risk Behaviors

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Risk Factors That Contribute to the Maintenance of Sinus Rhythm

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Complex and Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX)